SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. – VRCA
Pomerantz LLP is investigating claims on behalf of investors of Verrica Pharmaceuticals Inc.. Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Verrica and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. On June 29, 2020, Verrica announced receipt … Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. – VRCA Continue Reading


In accordance with the results of the Special General Meeting (the “SGM”), the Company has today submitted an application for delisting to the Oslo Stock Exchange (the “OSE”). The Company cannot predict whether the OSE will grant the Company’s request to delist its common shares from the OSE, but in light of the reasons supporting …
Cipherloc Corporation a developer of advanced encryption technology for the post-quantum era, today announced that Andrew Borene, the President and CEO, authored an article in The Hill on February 28, 2020. The article, entitled “Indictment of Chinese Hackers is wake-up call for better public-private cooperation,” addressed the increasing risks to businesses in the U.S. and our allied …
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 10, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Hebron Technology Co., Ltd. investors who purchased securities between April 24, 2020 and June 3, 2020, inclusive (the “Class Period”). If you suffered a loss on your Hebron investments or would …